ASCYX | VEXPX | ASCYX / VEXPX | |
Total Expense Ratio | 0.86 | 0.44 | 195% |
Annual Report Gross Expense Ratio | 1.02 | 0.44 | 232% |
Fund Existence | 4 years | 58 years | - |
Gain YTD | 3.066 | 4.828 | 63% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 500000 | 3000 | 16,667% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 197M | 20.5B | 1% |
Annual Yield % from dividends | 0.00 | 0.39 | - |
Returns for 1 year | 6.52 | 0.69 | 948% |
Returns for 3 years | 23.64 | 21.90 | 108% |
Returns for 5 years | N/A | 11.42 | - |
Returns for 10 years | N/A | 32.23 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
ZALT | 31.76 | 0.04 | +0.13% |
Innovator U.S. Equity 10 Buffr ETF - Qt | |||
SVAL | 33.99 | 0.01 | +0.03% |
iShares US Small Cap Value Factor ETF | |||
XTAP | 39.47 | N/A | N/A |
Innovator US Equity Acltd Pls ETF™ April | |||
SJLD | 25.51 | N/A | N/A |
SanJac Alpha Low Duration ETF | |||
XBI | 93.43 | -0.69 | -0.73% |
SPDR® S&P Biotech ETF |